# Yonsei University

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/yonsei-university/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 65.8 |
| Citations | 13,619,837 |
| City | Seoul |
| Country | KR |
| Description | Yonsei University is a research organisation in Seoul, KR. OpenAlex records 181,416 works and 13,619,837 citations for it. 44,037 researchers list it as their most recent affiliation. |
| Homepage | https://www.yonsei.ac.kr |
| OpenAlex ID | https://openalex.org/I193775966 |
| Region | Seoul |
| Researchers | 44,037 |
| ROR ID | https://ror.org/01wjejq96 |
| Type | education |
| Works | 181,416 |

## University papers

Showing 12 of 251.

- [A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer](https://scholariq.org/papers/a-multigene-assay-to-predict-recurrence-of-tamoxifen-treated-node-negative/)
- [Osimertinib in Untreated <i>EGFR</i> -Mutated Advanced Non–Small-Cell Lung Cancer](https://scholariq.org/papers/osimertinib-in-untreated-i-egfr-i-mutated-advanced-non-small-cell-lung-cancer/)
- [Trastuzumab plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer](https://scholariq.org/papers/trastuzumab-plus-adjuvant-chemotherapy-for-operable-her2-positive-breast-cancer/)
- [Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis](https://scholariq.org/papers/pathological-complete-response-and-long-term-clinical-benefit-in-breast-cancer/)
- [Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer](https://scholariq.org/papers/durvalumab-after-chemoradiotherapy-in-stage-iii-non-small-cell-lung-cancer/)
- [A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement](https://scholariq.org/papers/a-new-definition-for-metabolic-dysfunction-associated-fatty-liver-disease-an/)
- [The B73 Maize Genome: Complexity, Diversity, and Dynamics](https://scholariq.org/papers/the-b73-maize-genome-complexity-diversity-and-dynamics/)
- [Improved Survival with an Implanted Defibrillator in Patients with Coronary Disease at High Risk for Ventricular Arrhythmia](https://scholariq.org/papers/improved-survival-with-an-implanted-defibrillator-in-patients-with-coronary/)
- [Age at onset of mental disorders worldwide: large-scale meta-analysis of 192 epidemiological studies](https://scholariq.org/papers/age-at-onset-of-mental-disorders-worldwide-large-scale-meta-analysis-of-192/)
- [Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial](https://scholariq.org/papers/pembrolizumab-versus-chemotherapy-for-previously-untreated-pd-l1-expressing/)
- [Osimertinib or Platinum–Pemetrexed in <i>EGFR</i> T790M–Positive Lung Cancer](https://scholariq.org/papers/osimertinib-or-platinum-pemetrexed-in-i-egfr-i-t790m-positive-lung-cancer/)
- [A multisociety Delphi consensus statement on new fatty liver disease nomenclature](https://scholariq.org/papers/a-multisociety-delphi-consensus-statement-on-new-fatty-liver-disease/)

## University researchers

- [Beom Kyung Kim](https://scholariq.org/researchers/beom-kyung-kim/)
- [Heung Dong Kim](https://scholariq.org/researchers/heung-dong-kim/)
- [Jong Ho Moon](https://scholariq.org/researchers/jong-ho-moon/)
- [Ara Ko](https://scholariq.org/researchers/ara-ko/)
- [Byungjin Hwang](https://scholariq.org/researchers/byungjin-hwang/)
- [Chang Ouk Kim](https://scholariq.org/researchers/chang-ouk-kim/)
- [Jung‐Woo Son](https://scholariq.org/researchers/jung-woo-son/)
- [Jong Weon Lee](https://scholariq.org/researchers/jong-weon-lee/)
- [Soo Kyung Park](https://scholariq.org/researchers/soo-kyung-park/)
- [Kyunguk Jeong](https://scholariq.org/researchers/kyunguk-jeong/)
- [Bomgyeol Kim](https://scholariq.org/researchers/bomgyeol-kim/)
- [Su-Hyeon Lee](https://scholariq.org/researchers/su-hyeon-lee/)
- [Jiyoung Shin](https://scholariq.org/researchers/jiyoung-shin/)
- [Hyunsik Sim](https://scholariq.org/researchers/hyunsik-sim/)
- [Suebin Park](https://scholariq.org/researchers/suebin-park/)

## University top topics

Showing 8 of 25.

- [Particle physics theoretical and experimental studies](https://scholariq.org/topics/particle-physics-theoretical-and-experimental-studies/)
- [Gastric Cancer Management and Outcomes](https://scholariq.org/topics/gastric-cancer-management-and-outcomes/)
- [Quantum Chromodynamics and Particle Interactions](https://scholariq.org/topics/quantum-chromodynamics-and-particle-interactions/)
- [Liver Disease Diagnosis and Treatment](https://scholariq.org/topics/liver-disease-diagnosis-and-treatment/)
- [Advanced Sensor and Energy Harvesting Materials](https://scholariq.org/topics/advanced-sensor-and-energy-harvesting-materials/)
- [High-Energy Particle Collisions Research](https://scholariq.org/topics/high-energy-particle-collisions-research/)
- [Semiconductor materials and devices](https://scholariq.org/topics/semiconductor-materials-and-devices/)
- [Hepatocellular Carcinoma Treatment and Prognosis](https://scholariq.org/topics/hepatocellular-carcinoma-treatment-and-prognosis/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.